Pulsatilla Saponin D

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NamePulsatilla Saponin D
Drug Alias NameSB-365
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitorsAngiogenesis inhibitors
TargetsTubulin
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSb
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSbpharmaceutical Ind.Co Ltd
Active IndicationsN/A
Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A